Lv51
1270 积分 2024-01-12 加入
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets
5天前
已完结
Clinical characteristics of anti‐AChR‐MuSK‐LRP4 antibody‐negative myasthenia gravis in China
5天前
已完结
Treatment of autoimmune myasthenia gravis
10天前
已完结
Therapeutic options in autoimmune myasthenia gravis
10天前
已完结
Maintenance immunosuppression in myasthenia gravis
10天前
已完结
Maintenance immunosuppression in myasthenia gravis, an update
25天前
已完结
Maintenance immunosuppression in myasthenia gravis, an update
1个月前
已完结
Assessing the symptom control provided by ravulizumab or efgartigimod in myasthenia gravis: an evaluation of the patient experience of 2 different treatment approaches
2个月前
已完结
Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees
2个月前
已完结
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
3个月前
已完结
皖公网安备34019202002308
